SFM Fetal Therapy Practice Guidelines: Intrauterine Blood Transfusion
Journal of Fetal Medicine · 01.12.2023 · 10 (04) · 187-194
DOI: 10.1055/s-0044-1779752 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Fetal Medicine, erschienen am 01.12.2023. Verfasst von Seneesh Kumar Vikraman und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Despite routine antenatal anti-D prophylaxis with immunoglobulin, Rh alloimmunization and hemolytic disease of the fetus and newborn continue to occur due to a myriad of reasons. Intrauterine intravascular transfusion (IUT) or fetal blood transfusion is a therapeutic prenatal procedure in which specifically prepared and treated unit of donor red blood cells is injected intravascularly into the umbilical vein under ultrasound guidance. Originally introduced in the year 1963, it continues to be the standard treatment for severe fetal anemia. The objective of this guideline is to provide an evidence-based update of IUT for the perinatal healthcare providers.
Zitieren
APA
Vikraman, S. K., & Krishnan, M. (2023). SFM Fetal Therapy Practice Guidelines: Intrauterine Blood Transfusion. Journal of Fetal Medicine, 10(04), 187-194. https://doi.org/10.1055/s-0044-1779752
Vancouver
Vikraman SK, Krishnan M. SFM Fetal Therapy Practice Guidelines: Intrauterine Blood Transfusion. Journal of Fetal Medicine. 2023;10(04):187-194. doi:10.1055/s-0044-1779752
BibTeX
@article{Vikraman2023,
author = {Vikraman, Seneesh Kumar and Krishnan, Manikandan},
title = {SFM Fetal Therapy Practice Guidelines: Intrauterine Blood Transfusion},
journal = {Journal of Fetal Medicine},
year = {2023},
volume = {10},
number = {04},
pages = {187--194},
doi = {10.1055/s-0044-1779752}
}
EUVIMED